Revolution Medicines, Inc.

RVMD

$210.87

+0.78%

N/A+$1.64

Healthcare

Biotechnology

NASDAQ

Active Trading

Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel ...

Financial Highlights of RVMD

Profitability trend

Latest / TTM · 6 periods

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-23.80x

n/a

Debt / Equity

0.25

n/a

Current Ratio

11.38

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-23.80x

Debt / Equity

0.25

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	100.0%	100.0%	100.0%	0.0%	0.0%	—
Operating MarginOperating income as a percentage of revenue.	-639.7%	-730.0%	-4207.1%	0.0%	0.0%	—
Net MarginNet income as a percentage of revenue.	-636.6%	-703.0%	-3768.3%	0.0%	0.0%	—
EBITDA MarginEBITDA divided by revenue.	-611.6%	-676.8%	-3715.7%	0.0%	0.0%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-636.6%	-704.1%	-3798.7%	0.0%	0.0%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	9.77	10.65	13.06	14.20	7.14	—
Quick RatioLiquid assets divided by current liabilities.	9.77	10.65	13.06	14.20	7.14	—
Cash RatioCash and equivalents divided by current liabilities.	1.80	2.60	4.84	3.31	1.32	—
Debt / AssetsDebt as a share of total assets.	9.0%	7.9%	4.3%	5.3%	6.7%	—
Debt / EquityDebt compared with shareholder equity.	0.11	0.09	0.05	0.06	0.10	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	4.96x	7.57x	9.23x	0.00x	0.00x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	0.00x	0.00x	0.00x	0.00x	0.26x	—
Asset TurnoverRevenue generated per dollar of assets.	0.04x	0.04x	0.01x	0.00x	0.00x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.06x	0.06x	0.01x	0.00x	0.00x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-10.19x	-7.73x	-7.43x	-12.22x	-13.39x	—
P/B RatioPrice paid for each dollar of book value.	3.04x	2.80x	1.78x	3.24x	9.28x	—
P/S RatioPrice paid for each dollar of sales.	62.35x	54.28x	280.24x	0.00x	0.00x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-11.92x	-8.16x	-9.06x	-12.92x	-16.57x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer